Most Read Articles
3 days ago
Early screening for gestational diabetes does not improve the composite perinatal outcomes in obese women, reveals a study.
Audrey Abella, 3 days ago
A novel, investigational vaginal pH regulator (VPR) – a nonhormonal, water-based, petroleum-free contraceptive vaginal gel – improved genitourinary (GU) side effects and sexual satisfaction in women who are at risk of pregnancy but are not aiming to conceive, interim findings from the phase III AMPOWER* trial show.
Pearl Toh, 21 May 2020
A levonorgestrel (LNG)-releasing intrauterine device (IUD) maintains high contraceptive efficacy up to 6 years, which is beyond the 5-year period it is currently approved for, according to data from the Mirena Extension Trial (MET) released during the ACOG 2020 Meeting.
12 Dec 2019
Rotavirus (RV) is highly contagious. Globally, 2 million children are hospitalized and more than 500,000 die annually from RV associated gastroenteritis. Therefore, vaccination is imperative for the prevention of RV infections.

Cardiometabolic profile moderately unfavourable in middle-aged PCOS patients

24 Jan 2020

Middle-aged women with polycystic ovary syndrome (PCOS) exhibit only a moderately unfavourable cardiometabolic profile despite having an increased body mass index (BMI) and waist circumference, as reported in a study.

The cross-sectional study involved 200 PCOS patients and 200 matched controls, and the average age of the overall population was 51 years. Researchers assessed anthropometrics, insulin, lipid levels, prevalence of metabolic syndrome and type II diabetes status. They also calculated 10‐year Framingham risk score, the cardiovascular health score and carotid intima‐media thickness (cIMT).

Compared with controls, PCOS patients were more likely to have increased waist circumference and BMI and were predisposed to hypertension (p<0.001).

There were no significant between-group differences in the prevalence rates of type II diabetes and metabolic syndrome, as well as in lipid levels. However, cIMT was lower in in the PCOS group (p<0.001).

The estimated cardiovascular health and 10‐year cardiovascular disease (CVD) risk were likewise similar in the PCOS and control groups.

Findings of the present study point to a need for long‐term follow‐up of women with PCOS in order to establish the long‐term risk of CVD, the researchers said. “[A]lthough some metabolic disturbances were present in our large cohort of middle‐aged women with PCOS, we found no evidence for premature atherosclerosis or an increased risk for future CVD. Only time will tell whether this will indeed translate into a better cardiovascular health in women with PCOS than was previously anticipated.”

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
3 days ago
Early screening for gestational diabetes does not improve the composite perinatal outcomes in obese women, reveals a study.
Audrey Abella, 3 days ago
A novel, investigational vaginal pH regulator (VPR) – a nonhormonal, water-based, petroleum-free contraceptive vaginal gel – improved genitourinary (GU) side effects and sexual satisfaction in women who are at risk of pregnancy but are not aiming to conceive, interim findings from the phase III AMPOWER* trial show.
Pearl Toh, 21 May 2020
A levonorgestrel (LNG)-releasing intrauterine device (IUD) maintains high contraceptive efficacy up to 6 years, which is beyond the 5-year period it is currently approved for, according to data from the Mirena Extension Trial (MET) released during the ACOG 2020 Meeting.
12 Dec 2019
Rotavirus (RV) is highly contagious. Globally, 2 million children are hospitalized and more than 500,000 die annually from RV associated gastroenteritis. Therefore, vaccination is imperative for the prevention of RV infections.